Search

Search Constraints

You searched for: Author/Creator Ancuta Codrina author non-byline.

Search Results

1. A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study. Issue 1 (23rd October 2014)

2. Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort. Issue 2 (3rd November 2022)

3. Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis. Issue 10 (25th March 2016)

4. Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database. Issue 6 (30th June 2014)

5. Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis. Issue 9 (21st June 2019)

6. Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis. Issue 9 (21st September 2019)

7. Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort. Issue 5 (11th May 2019)

8. Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort. Issue 5 (9th March 2019)

9. Significant weight loss in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Issue 8 (25th March 2020)